Literature DB >> 9440695

The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control.

I Garkavtsev1, I A Grigorian, V S Ossovskaya, M V Chernov, P M Chumakov, A V Gudkov.   

Abstract

The candidate tumour-suppressor gene ING1 has been identified by using the genetic suppressor element (GSE) methodology. ING1 encodes a nuclear protein, p33ING1, overexpression of which inhibits growth of different cell lines. The properties of p33ING1 suggest its involvement in the negative regulation of cell proliferation and in the control of cellular ageing, anchorage dependence and apoptosis. These cellular functions depend largely on the activity of p53, a tumour-suppressor gene that determines the cellular response to various types of stress. Here we report that the biological effects of ING1 and p53 are interrelated and require the activity of both genes: neither of the two genes can, on its own, cause growth inhibition when the other one is suppressed. Furthermore, activation of transcription from the p21/WAF1 promoter, a key mechanism of p53-mediated growth control, depends on the expression of ING1. A physical association between p33ING1 and p53 proteins has been detected by immunoprecipitation. These results indicate that p33ING1 is a component of the p53 signalling pathway that cooperates with p53 in the negative regulation of cell proliferation by modulating p53-dependent transcriptional activation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9440695     DOI: 10.1038/34675

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  80 in total

1.  Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage.

Authors:  K Webley; J A Bond; C J Jones; J P Blaydes; A Craig; T Hupp; D Wynford-Thomas
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

2.  UV induces nucleolar translocation of ING1 through two distinct nucleolar targeting sequences.

Authors:  M Scott; F M Boisvert; D Vieyra; R N Johnston; D P Bazett-Jones; K Riabowol
Journal:  Nucleic Acids Res       Date:  2001-05-15       Impact factor: 16.971

Review 3.  The ING family tumor suppressors: from structure to function.

Authors:  Almass-Houd Aguissa-Touré; Ronald P C Wong; Gang Li
Journal:  Cell Mol Life Sci       Date:  2010-08-29       Impact factor: 9.261

4.  Critical determinants for chromatin binding by Saccharomyces cerevisiae Yng1 exist outside of the plant homeodomain finger.

Authors:  Adam Chruscicki; Vicki E Macdonald; Barry P Young; Christopher J R Loewen; Leann J Howe
Journal:  Genetics       Date:  2010-03-29       Impact factor: 4.562

5.  Down-regulation of the inhibitor of growth 1 (ING1) tumor suppressor sensitizes p53-deficient glioblastoma cells to cisplatin-induced cell death.

Authors:  Ute Gesche Tallen; Matthias Truss; Frank Kunitz; Sven Wellmann; Brad Unryn; Brigitte Sinn; Ulrike Lass; Sonja Krabbe; Nikola Holtkamp; Christian Hagemeier; Reinhard Wurm; Guenter Henze; Karl T Riabowol; Andreas von Deimling
Journal:  J Neurooncol       Date:  2007-09-01       Impact factor: 4.130

6.  Subcellular targeting of p33ING1b by phosphorylation-dependent 14-3-3 binding regulates p21WAF1 expression.

Authors:  Wei Gong; Michael Russell; Keiko Suzuki; Karl Riabowol
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

7.  Non-small cell lung cancer is susceptible to induction of DNA damage responses and inhibition of angiogenesis by telomere overhang oligonucleotides.

Authors:  Neelu Puri; Ryan T Pitman; Richard E Mulnix; Terrianne Erickson; Audra N Iness; Connie Vitali; Yutong Zhao; Ravi Salgia
Journal:  Cancer Lett       Date:  2013-09-14       Impact factor: 8.679

8.  Genetic synthetic lethality screen at the single gene level in cultured human cells.

Authors:  A H Simons; N Dafni; I Dotan; Y Oron; D Canaani
Journal:  Nucleic Acids Res       Date:  2001-10-15       Impact factor: 16.971

9.  Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex.

Authors:  A Nourani; Y Doyon; R T Utley; S Allard; W S Lane; J Côté
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

10.  Downregulation of nuclear expression of the p33(ING1b) inhibitor of growth protein in invasive carcinoma of the breast.

Authors:  G S Nouman; J J Anderson; S Crosier; J Shrimankar; J Lunec; B Angus
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.